📣 VC round data is live. Check it out!

BactiQuant Valuation Multiples

Discover revenue and EBITDA valuation multiples for BactiQuant and similar public comparables like Orege, LiqTech International, Norditek Group, Global Clean Energy and more.

BactiQuant Overview

About BactiQuant

BactiQuant AS focuses on delivering technology that ensures optimum usage and handling of water around the world. The company's activities include the development, production, sale and service of BactiQuant Online and BactiQuant Mobile Lab with associated test kits/substrate for the quantification and detection of bacteria in water. Its segments are Aquaculture, Data Centres, Oil & Gas, Water Utility, Industry, and Pharma. The group's products are BQ Online 2.0 PRO, BQ Online, BQ Mobile Lab, and Analysis Kits.


Founded

1999

HQ

Denmark

Employees

12

Financials (FY)

Revenue: $1M
EBITDA: ($2M)

EV

$17M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

BactiQuant Financials

BactiQuant reported last fiscal year revenue of $1M and negative EBITDA of ($2M).

In the same fiscal year, BactiQuant generated ($342K) in gross profit, ($2M) in EBITDA losses, and had net loss of ($2M).


BactiQuant P&L

In the most recent fiscal year, BactiQuant reported revenue of $1M and EBITDA of ($2M).

BactiQuant is unprofitable as of last fiscal year, with gross margin of (26%), EBITDA margin of (125%), and net margin of (166%).

See analyst estimates for BactiQuant
Last FY202320242025202620272028
Revenue$1M$2M$1M$1M
Gross Profit($342K)($118K)($523K)($342K)
Gross Margin(26%)(6%)(47%)(26%)
EBITDA($2M)($2M)($2M)($2M)
EBITDA Margin(125%)(83%)(144%)(125%)
EBIT Margin(150%)(89%)(176%)(150%)
Net Profit($2M)($2M)($2M)($2M)
Net Margin(166%)(107%)(191%)(166%)

Financial data powered by Morningstar, Inc.

BactiQuant Stock Performance

BactiQuant has current market cap of $19M, and enterprise value of $17M.

Market Cap Evolution


BactiQuant's stock price is $0.50.

BactiQuant share price decreased by 3.1% in the last 30 days, and increased by 6.2% in the last year.

BactiQuant has an EPS (earnings per share) of $-0.06.

See more trading valuation data for BactiQuant
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$17M$19M0.3%-3.1%20.0%6.2%$-0.06

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

BactiQuant Valuation Multiples

BactiQuant trades at 13.3x EV/Revenue multiple, and (10.7x) EV/EBITDA.

See NTM and 2027E valuation multiples for BactiQuant

BactiQuant Financial Valuation Multiples

As of May 26, 2026, BactiQuant has market cap of $19M and EV of $17M.

BactiQuant has a P/E ratio of (8.7x).

Last FY202320242025202620272028
EV/Revenue13.3x9.0x15.4x13.3x
EV/EBITDA(10.7x)(10.9x)(10.8x)(10.7x)
EV/EBIT(8.9x)(10.2x)(8.8x)(8.9x)
EV/Gross Profit(50.6x)(146.7x)(33.0x)(50.6x)
P/E(8.7x)(9.2x)(8.7x)(8.7x)
EV/FCF(10.5x)(12.7x)(8.5x)(10.5x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified BactiQuant Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

BactiQuant Margins & Growth Rates

In the most recent fiscal year, BactiQuant reported gross margin of (26%), EBITDA margin of (125%), and net margin of (166%).

See estimated margins and future growth rates for BactiQuant

BactiQuant Margins

Last FY20242025202720282029
Gross Margin(26%)(47%)(26%)
EBITDA Margin(125%)(144%)(125%)
EBIT Margin(150%)(176%)(150%)
Net Margin(166%)(191%)(166%)
FCF Margin(126%)(181%)(126%)

BactiQuant Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(42%)16%
Gross Profit Growth344%(35%)
EBITDA Growth1%1%
EBIT Growth16%(1%)
Net Profit Growth5%1%
FCF Growth49%(19%)

Data powered by FactSet, Inc. and Morningstar, Inc.

BactiQuant Operational KPIs

BactiQuant's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

Access forward-looking KPIs for BactiQuant
Last FY202320242025202620272028
Revenue per Employee$0.1M
Opex per Employee$0.1M
Opex to Revenue124%82%129%124%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

BactiQuant Competitors

BactiQuant competitors include Orege, LiqTech International, Norditek Group, Global Clean Energy, PowerHouse Energy Group, M Vest Water, GEL, De.mem, Bioextrax and EcoUp.

Most BactiQuant public comparables operate across Waste & Environmental Services.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Orege27.0x(16.1x)
LiqTech International1.7x1.5x(4.7x)
Norditek Group2.1x10.4x
Global Clean Energy
PowerHouse Energy Group21.8x9.3x(2.3x)(3.3x)
M Vest Water6.7x6.4x(17.3x)(19.1x)
GEL
De.mem0.6x0.5x11.3x7.4x

This data is available for Pro users. Sign up to see all BactiQuant competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About BactiQuant

When was BactiQuant founded?BactiQuant was founded in 1999.
Where is BactiQuant headquartered?BactiQuant is headquartered in Denmark.
How many employees does BactiQuant have?As of today, BactiQuant has over 12 employees.
Is BactiQuant publicly listed?Yes, BactiQuant is a public company listed on Nasdaq Copenhagen.
What is the stock symbol of BactiQuant?BactiQuant trades under BACTIQ ticker.
When did BactiQuant go public?BactiQuant went public in 2021.
Who are competitors of BactiQuant?BactiQuant main competitors include Orege, LiqTech International, Norditek Group, Global Clean Energy, PowerHouse Energy Group, M Vest Water, GEL, De.mem, Bioextrax, EcoUp.
What is the current market cap of BactiQuant?BactiQuant's current market cap is $19M.
What is the current revenue of BactiQuant?BactiQuant's last fiscal year revenue is $1M.
What is the current EV/Revenue multiple of BactiQuant?Current revenue multiple of BactiQuant is 13.3x.
Is BactiQuant profitable?No, BactiQuant is not profitable.
How many companies BactiQuant has acquired to date?BactiQuant hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies BactiQuant has invested to date?BactiQuant hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to BactiQuant

Lists including BactiQuant

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial